Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer ; volume:9 ; number:1 ; day:12 ; month:2 ; year:2019 ; pages:1-6 ; date:12.2019
Scientific reports ; 9, Heft 1 (12.2.2019), 1-6, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Martin, Nikolas Tim
Roy, Dominic Guy
Workenhe, Samuel Tekeste
van den Wollenberg, Diana J. M.
Hoeben, Rob C.
Mossman, Karen Louise
Bell, John Cameron
Bourgeois-Daigneault, Marie-Claude
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-38385-7
- URN
-
urn:nbn:de:101:1-2019031123500016337037
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martin, Nikolas Tim
- Roy, Dominic Guy
- Workenhe, Samuel Tekeste
- van den Wollenberg, Diana J. M.
- Hoeben, Rob C.
- Mossman, Karen Louise
- Bell, John Cameron
- Bourgeois-Daigneault, Marie-Claude
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Combining Oncolytic Virotherapy with Target Therapy in Bladder Cancer
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Combining Oncolytic Virotherapy with Target Therapy in Bladder Cancer
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy